Latest news with #AndrewMcLaughlin
BBC News
22-07-2025
- General
- BBC News
Greystones Farm nature reserve could soon double in size
A grassland habitat could double in size as an old farming approach is set to be used to boost biodiversity. Gloucestershire Wildlife Trust's proposal for the Greystones Farm nature reserve in Bourton-on-the-Water involves reinstating a traditional beef herd for trust said this change will help to increase the area of farmed land that also benefits nature, supporting farmland birds such as McLaughlin, CEO of Gloucestershire Wildlife Trust, said it will give them "better control over how the site is grazed" and "boost nature". During the trial, the fields nearest the farm buildings will be rested for longer periods, allowing the grasses and flowers to grow during the summer months. This will boost the number of seeds and nectar for insects, mammals and is hoped this will also encourage more plants to thrive in this "precious" habitat, the trust said. Mr McLaughlin said the "scale and impact" of the world's ecological emergency means "it is vital that we are doing everything we can to give nature a boost"."This is particularly the case on our own land that we hold for the benefit of wildlife and people's connection with the natural world," he said."Turnstone Farming Company have done a fantastic job in managing the dairy herd at Greystones Farm nature reserve over the last 10 years or so, and we thank them for all their efforts."It's an exciting new chapter for the Greystones Farm nature reserve that reflects its recent and ancient past, and we are looking forward to working in close partnership with the local community as we seek to bring this to reality in 2026."
TECHx
17-02-2025
- Business
- TECHx
SandboxAQ, Deloitte Strengthen Partnership to Transform Healthcare - TECHx Media SandboxAQ, Deloitte Strengthen Partnership to Transform Healthcare
SandboxAQ has announced the expansion of its strategic alliance with Deloitte, bringing SandboxAQ's AI-driven LQM (Large Quantitative Models) simulation solutions to organizations globally. This collaboration aims to accelerate product development across various industries, particularly biopharma, leveraging both SandboxAQ's advanced AQBioSim and AQChemSim solutions, along with Deloitte's vast service capabilities in data and life sciences. Andrew McLaughlin, Chief Operating Officer at SandboxAQ, expressed excitement over the expanded partnership, stating, 'AI simulation with Large Quantitative Models represents the next evolution of AI, transforming how organizations create value for their customers in ways that Large Language Models cannot.' The integration of LQMs with Deloitte's Atlas AI™ knowledge graph will enable SandboxAQ's scientists to extract new, clinically relevant hypotheses, enhancing drug discovery processes. This collaboration combines Deloitte's engineering expertise and industry knowledge to streamline and accelerate drug discovery, utilizing AI-powered molecular simulations for deeper insights into drug development and treatment responses. Aditya Kudumala, Principal at Deloitte Consulting LLP, emphasized the strength of the partnership, saying, 'Together, we aim to advance drug discovery and materials science for leading academic, commercial, and public sector entities.' With this expanded alliance, the companies aim to drive innovation and efficiency in drug development, ultimately reshaping the healthcare and life sciences sectors.
Tahawul Tech
17-02-2025
- Business
- Tahawul Tech
SandboxAQ expands alliance with Deloitte to offer AI simulation software solutions
SandboxAQ announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organisations worldwide. SandboxAQ's AQBioSim and AQChemSim solutions leverage Large Quantitative Models (LQMs) to accelerate product development across a broad range of sectors, including biopharma. Deloitte will augment these offerings with their data and life sciences experience combined with their deep business and technology acumen. This collaboration will help transform nearly every facet of healthcare and life sciences. 'SandboxAQ is excited to expand its long-standing strategic alliance with Deloitte, whose relationships with some of the world's largest organisations will accelerate the adoption of our quantitative AI technologies', said Andrew McLaughlin, Chief Operating Officer of SandboxAQ. 'AI simulation with Large Quantitative Models represents the next evolution of AI and will have a transformative impact on how organisations create value for their customers in ways that Large Language Models cannot'. Using LQMs in collaboration with Deloitte's Atlas AI™ knowledge graph capabilities will allow SandboxAQ's scientists to automatically extract new clinical hypotheses from literature, highlighting only those most likely to be correct. With Atlas AI, Deloitte brings its engineering skills and industry experience together to accelerate the drug discovery process. Deloitte's Atlas AI team and SandboxAQ will also collaborate with pharmaceutical companies and other organisations on data evaluation, exploratory data analysis, and AI model testing and evaluation to enhance the speed and accuracy of the drug discovery processes. Along the way, SandboxAQ's AI-powered molecular simulations will generate vast amounts of highly accurate, physics-based data, delivering new insights for drug development, target ID, and treatment response. 'With this expansion of our alliance, we're able to combine our extensive experience in life sciences, data, and research with SandboxAQ's leadership in AI simulation and Large Quantitative Models', said Aditya Kudumala, principal, Deloitte Consulting LLP. 'Together, we aim to advance drug discovery and materials science for leading academic, commercial, and public sector entities'. Organisations interested in this expanded Deloitte and SandboxAQ Alliance can contact partners@ Image Credit: SandboxAQ
